Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Allarity Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- +3 vs. Q4 2024
- Shares held
- 92.4K
- −12.1K (−11.6%) vs. Q4 2024
- Total value
- $86.5K
- −$35.7K (−29.2%) vs. Q4 2024
- New holders
- 6
- 2 more added
- Sold out
- 3
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $1.65M |
| Q1 2026 | 14 | $1.04M |
| Q4 2025 | 16 | $1.40M |
| Q3 2025 | 11 | $1.63M |
| Q2 2025 | 10 | $197.0K |
| Q1 2025 | 9 | $86.5K |
| Q4 2024 | 6 | $122.3K |
| Q3 2024 | 4 | $46.2K |
| Q2 2024 | 9 | $107.8K |
| Q1 2024 | 4 | $11.7K |
| Q4 2023 | 4 | $31.8K |
| Q3 2023 | 7 | $515.6K |
| Q2 2023 | 4 | $33.3K |
| Q1 2023 | 6 | $4.05K |
| Q4 2022 | 10 | $42.0K |
| Q3 2022 | 10 | $181.0K |
| Q2 2022 | 10 | $304.0K |
| Q1 2022 | 10 | $694.0K |
| Q4 2021 | 3 | $270.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Allarity Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 33,921 | $31.8K | 0.00% | +33,921 | New |
| Morgan Stanley | 23,311 | $21.8K | 0.00% | +23,311 | New |
| Corsair Capital Management, L.P. | 20,000 | $18.7K | 0.00% | +20,000 | New |
| Barclays PLC | 10,078 | $9.44K | 0.00% | +10,078 | New |
| Tower Research Capital LLC (TRC) | 4,705 | $4.41K | 0.00% | +439+10.3% | Added |
| UBS Group AG | 300 | $281 | 0.00% | +300 | New |
| Bank of America Corp | 38 | $36 | 0.00% | +16+72.7% | Added |
| Advisor Group Holdings, Inc. | 7 | $6 | 0.00% | +7 | New |
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −67,289−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −20,616−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −12,294−100.0% | Sold out |